David A. Sinclair Ph.D., A.O.

Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.

Arc Bio is revolutionizing microbial detection with a workflow that can be easily deployed in your own lab. The power of NGS. Without the learning curve. Arc Bio is an EdenRoc Sciences Company.

Cantata Bio is enabling researchers and clinicians to solve tomorrow’s most challenging scientific problems through novel, multiomic approaches that unlock access to genomic and metagenomic information at unprecedented levels. Combining propriety technologies with platform solutions, services, and cutting-edge bioinformatics and software, our unique approaches are solving complex problems, including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, metagenomics, and microbiome analysis. Our customers are positively impacting the fields of epigenetics, developmental biology, cancer research, evolutionary biology, infectious disease, and more. Cantata Bio is based in Scotts Valley, California and Cambridge, Massachusetts. For more information on Cantata Bio, its technology, and offerings, visit www.cantatabio.com.

Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivarium™, incorporating Vium Smart Housing™, Vium Cloud infrastructure, and online Research Suite software, empowers scientists to optimize advances in bioengineered research models in ways previously not possible. Vium is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the “3 Rs,” the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical and computational drug discovery companies to academia and novel therapeutic labs. Investors include Lux Capital, Data Collective, Dolby Family Ventures, AME Cloud Ventures, and Founders Fund. For more information, please visit www.vium.com.

Fully Aligned Co was founded by Harvard Professor Dr. David A. Sinclair and world-renowned longevity expert Serena Poon as a consumer wellness company dedicated to promoting access to knowledge, products, and tools that promote personal well-being and longevity. Our primary domains of engagement include longevity & aging science, exercise & performance optimization, and holistic well-being of the body and mind.

Sign up at www.tallyhealth.com

We envision a world where breakthroughs in longevity are accelerated and made accessible because the most brilliant researchers, laboratories, academic institutions, regulators and drug companies are innovating and collaborating in new and innovative ways

Animal Bioscience is dedicated to developing products to slow aging and the problems associated with aging in companion animals. We leverage clinically proven science, our team’s global expertise and quality manufacturing to extend the health and vitality of animals. Our mission is to bring longevity science revolutionizing human medicine to redefine aging in companion animals. We have built a platform that targets aging at the cellular level to extend the healthspan and delay the onset of age-related diseases in companion animals. Our soft chew, daily supplement system for dogs Leap Years®, is now available for order.